GLP-1 Drugs May Lower Cancer Risk

New research is sparking buzz: GLP-1 drugs like Ozempic and Wegovy, made for diabetes and weight loss, might slash cancer risk. Early studies link them to reduced chances of six out of seven cancers, including breast, liver, and lung. Experts caution it’s still correlation—not proof—but the data is compelling. One study found women on these meds had 30% lower breast cancer risk, possibly due to anti-inflammatory effects. Clinical trials are now underway to explore how these drugs might fight cancer through immune and inflammation pathways. The future could see weight-loss meds becoming cancer-prevention tools. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8f0f0a42cf6ed947